1. Home
  2. SLNO vs ORLA Comparison

SLNO vs ORLA Comparison

Compare SLNO & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
    SELLHOLDBUYas of a day ago
  • ORLA
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • SLNO 1999
  • ORLA 2007
  • Country
  • SLNO United States
  • ORLA Canada
  • Employees
  • SLNO N/A
  • ORLA N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ORLA Precious Metals
  • Sector
  • SLNO Health Care
  • ORLA Basic Materials
  • Exchange
  • SLNO Nasdaq
  • ORLA Nasdaq
  • Market Cap
  • SLNO 2.3B
  • ORLA 2.3B
  • IPO Year
  • SLNO 2014
  • ORLA N/A
  • Fundamental
  • Price
  • SLNO $71.45
  • ORLA $9.34
  • Analyst Decision
  • SLNO Strong Buy
  • ORLA Buy
  • Analyst Count
  • SLNO 8
  • ORLA 2
  • Target Price
  • SLNO $95.75
  • ORLA $6.13
  • AVG Volume (30 Days)
  • SLNO 1.8M
  • ORLA 1.5M
  • Earning Date
  • SLNO 05-08-2025
  • ORLA 03-18-2025
  • Dividend Yield
  • SLNO N/A
  • ORLA N/A
  • EPS Growth
  • SLNO N/A
  • ORLA N/A
  • EPS
  • SLNO N/A
  • ORLA 0.27
  • Revenue
  • SLNO N/A
  • ORLA $343,918,000.00
  • Revenue This Year
  • SLNO N/A
  • ORLA $138.03
  • Revenue Next Year
  • SLNO N/A
  • ORLA $5.24
  • P/E Ratio
  • SLNO N/A
  • ORLA $33.22
  • Revenue Growth
  • SLNO N/A
  • ORLA 47.20
  • 52 Week Low
  • SLNO $36.61
  • ORLA $3.24
  • 52 Week High
  • SLNO $73.97
  • ORLA $9.62
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 82.97
  • ORLA 68.03
  • Support Level
  • SLNO $48.29
  • ORLA $9.05
  • Resistance Level
  • SLNO $73.97
  • ORLA $9.56
  • Average True Range (ATR)
  • SLNO 3.17
  • ORLA 0.49
  • MACD
  • SLNO 2.71
  • ORLA 0.01
  • Stochastic Oscillator
  • SLNO 91.28
  • ORLA 85.27

Stock Price Comparison Chart: SLNO vs ORLA

SLNO
ORLA
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202501020304050607080SLNO VS ORLA

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About ORLA Orla Mining Ltd.

Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the South Railroad and Lewis gold projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use